Differentiative therapy plus low dose chemotherapy as a post-remission maintenance treatment for poor prognosis AML and myelodysplastic syndrome patients.

被引：0
|
作者：
Ferrero, D
Grasso, M
Campa, E
Campana, S
Foli, C
Borchiellini, A
Pileri, A
机构：
[1] Azienda Osped S Giovanni Battista, Div Univ Ematol, Turin, Italy
[2] Azienda Osped S Croce & Carle, Div Ematol, Cuneo, Italy
[3] Osped E Agnelli, Div Med, Pinerolo, Italy
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4632
引用
收藏
页码：211B / 211B
页数：1
相关论文
共 50 条
  • [1] Post-remission maintenance treatment with low-dose chemotherapy plus differentiating agents can prolong remission duration and survival in poor risk AML and MDS patients
    Ferrero, D.
    Giai, V
    Genuardi, M.
    Dellacasa, C.
    Grasso, M.
    Bonferroni, M.
    Borrione, P.
    Ciravegna, G.
    Boccadoro, M.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 74 - 74
  • [2] A POST-REMISSION MAINTENANCE TREATMENT WITH LOW-DOSE CHEMOTHERAPY plus RETINOIDS AND DIHYDROXYLATED VITAMIN D3 MAY IMPROVE THE SURVIVAL OF POOR-PROGNOSIS AML/MDS PATIENTS
    Ferrero, D.
    Crisa, E.
    Marmont, F.
    Audisio, E.
    Frairia, C.
    Giai, V.
    Gatti, T.
    Festuccia, M.
    Bruno, B.
    Riera, L.
    Passera, R.
    Boccadoro, M.
    [J]. HAEMATOLOGICA, 2014, 99 : 306 - 307
  • [3] High-dose chemotherapy with autologous PDSCT as post-remission therapy for AML
    M Harada
    H Gondo
    F Kawano
    [J]. Bone Marrow Transplantation, 2001, 27 : 347 - 347
  • [4] High-dose chemotherapy with autologous PBSCT as post-remission therapy for AML
    Harada, M
    Gondo, H
    Kawano, F
    [J]. BONE MARROW TRANSPLANTATION, 2001, 27 (03) : 347 - 347
  • [5] LOW-DOSE CHEMOTHERAPY AND DIFFERENTIATING AGENTS AS POST-REMISSION MAINTENANCE PROLONGED DISEASE-FREE AND OVERALL SURVIVAL IN A CASE-CONTROL RETROSPECTIVE STUDY ON POOR PROGNOSIS AML/MDS PATIENTS
    Ferrero, D.
    Crisa, E.
    Gatti, T.
    Giai, V.
    Aguzzi, C.
    Marmont, F.
    Audisio, E.
    D'Ardia, S.
    Frairia, C.
    Bruno, B.
    Festuccia, M.
    Passera, R.
    Boccadoro, M.
    [J]. HAEMATOLOGICA, 2013, 98 : 25 - 26
  • [6] Preliminary experience with valproic acid in association to differentiative agents and low dose chemotherapy in poor prognosis AML
    Ferrero, D
    Campa, E
    Campana, S
    Dellacasa, C
    Boccadoro, M
    [J]. BLOOD, 2002, 100 (11) : 267B - 267B
  • [7] Survival improvement of poor-prognosis AML/MDS patients by maintenance treatment with low-dose chemotherapy and differentiating agents
    Ferrero, Dario
    Crisa, Elena
    Marmont, Filippo
    Audisio, Ernesta
    Frairia, Chiara
    Giai, Valentina
    Gatti, Tiziana
    Festuccia, Moreno
    Bruno, Benedetto
    Riera, Ludovica
    Passera, Roberto
    Boccadoro, Mario
    [J]. ANNALS OF HEMATOLOGY, 2014, 93 (08) : 1391 - 1400
  • [8] Survival improvement of poor-prognosis AML/MDS patients by maintenance treatment with low-dose chemotherapy and differentiating agents
    Dario Ferrero
    Elena Crisà
    Filippo Marmont
    Ernesta Audisio
    Chiara Frairia
    Valentina Giai
    Tiziana Gatti
    Moreno Festuccia
    Benedetto Bruno
    Ludovica Riera
    Roberto Passera
    Mario Boccadoro
    [J]. Annals of Hematology, 2014, 93 : 1391 - 1400
  • [9] A maintenance therapy with differentiating agents and low-dose chemotherapy increases remission duration and survival in high risk AML and MDS patients.
    Ferrero, D
    Dellacasa, C
    Bonferroni, M
    Grasso, M
    Campa, E
    Giai, V
    Genuardi, M
    Boccadoro, M
    [J]. BLOOD, 2005, 106 (11) : 232B - 232B
  • [10] Differentiating agents plus low-dose chemotherapy in the management of old/poor prognosis patients with acute myeloid leukemia or myelodysplastic syndrome
    Ferrero, D
    Campa, E
    Dellacasa, C
    Compana, S
    Foli, C
    Boccadoro, M
    [J]. HAEMATOLOGICA, 2004, 89 (05) : 619 - 620
12345